SWShanning Wan

Shanning Wan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shanning Wan has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Jianfang Zhang

    Department of Obstetrics and Gynecology, Xijing Hospital, Air force Medical University, No. 15 Changle West Road, Xi'an, 710033, Shaanxi, China.

    3 shared publications
  • Yinghui Dang

    Department of Obstetrics and Gynecology The First Affiliated Hospital of Air Force Medical University Xi'an China

    3 shared publications
  • Tingting Song

    Department of Obstetrics and Gynecology The First Affiliated Hospital of Air Force Medical University Xi'an China

    2 shared publications
  • Yu Li

    Department of Obstetrics and Gynecology The First Affiliated Hospital of Air Force Medical University Xi'an China

    2 shared publications
  • Yunyun Zheng

    A Department of Obstetrics and Gynecology, the First Affiliated Hospital Of AFMU (Air Force Medical University) , Xi'an , China

    2 shared publications
  • Biliang Chen

    Department of Obstetrics and Gynecology, The First Affiliated Hospital Of Air Force Medical University, Xi'an, Shaanxi, China

    1 shared publication

Latest Publications

  • Open Access

    Detection of submicroscopic chromosomal aberrations by chromosomal microarray analysis for the prenatal diagnosis of central nervous system abnormalities

    by Tingting Song, Ying Xu, Yu Li, Li Jia, Jiao Zheng, Yinghui Dang, Shanning Wan, Yunyun Zheng, Jianfang Zhang, Hong Yang

    Background: Central nervous system (CNS) abnormalities are a group of serious birth defects associated with high rates of stillbirths, infant death, or abnormal development, and various disease‐causing copy number variations play a much more important role in the etiology of CNS abnormalities. This study intends to present a retrospective study of the prenatal diagnosis and the pregnancy outcome of fetuses diagnosed with CNS abnormalities, and evaluate the clinical value of chromosomal microarray analysis (CMA) in prenatal diagnosis of CNS abnormalities.Methods: A total of 356 fetuses with CNS abnormalities with or without other ultrasound abnormalities subjected to invasive prenatal diagnosis at the first affiliated hospital of Air Force Medical University from January 2015 to August 2018. All cases have performed both karyotyping and CMA concurrently, but 20 fetuses with chromosome aneuploidy were excluded in the current study.Results: The CMA identified pathogenic copy number variants (pCNVs) in 27/336 (8.03%) fetuses, likely pCNVs in 8/336 (2.38%) fetuses, and variants of unknown significance (VOUS) in 11/336 (3.27%) fetuses. A total of 222 cases had single CNS abnormalities and the pCNVs detection rate was 5.86% (13/222), the remaining 114 cases including CNS abnormalities plus other structural abnormalities, ultrasonographic soft markers and two or more CNS abnormalities, the pCNVs detection rate was 12.3% (14/114).Conclusions: Fetuses with CNS abnormalities have a higher risk of chromosomal abnormalities, our study showed that CNVs play an important role in the etiology of CNS abnormalities. The application of CMA could increase the detection rate of pCNVs causing CNS abnormalities.


  • The Prenatal Diagnosis of Seven Fetuses with 7q11.23 Microdeletion or Microduplication

    by Yinghui Dang, Shanning Wan, Yunyun Zheng, Tingting Song, Chunyan Li, Yu Li, Jianfang Zhang

    Objective: There is scant information available about fetuses with 7q11.23 copy number variants (CNVs) found during pregnancy. We studied the clinical significance of 7q11.23 CNVs in prenatal diagnosis. Materials and methods: The amniocentesis was performed on pregnant women who underwent ultrasound (US) of fetal abnormalities. After karyotype analysis, CNVs were detected using BACs-on-Beads (BoBs) technique and chromosome microarray analysis (CMA). Results: Of seven fetuses with CNV of 7q11.23, five had microdeletions and two had microduplications. Case 1 had a 7q11.23 microdeletion along with other CNVs. Case 7 was a newborn with a normal phenotype and 7q11.23 microduplication. Conclusion: The CNVs in 7q11.23 results in many clinical manifestations, but the specificity of clinical features is not high. This study demonstrated that BoBs combined with CMA allows prenatal diagnosis of CNVs involving 7q11.23, and provide a clinical basis for prenatal diagnosis and genetic counseling of such CNVs.


  • Open Access

    Detection of 21q11.2‐q22.11 deletions in a fetus by NIPT

    by Yunyun Zheng, Biliang Chen, Shanning Wan, Hui Xu, Yinghui Dang, Tingting Song, Yu Li, Jianfang Zhang

    Background: Non‐invasive prenatal testing (NIPT) is extensively used in the detection of fetal trisomies 21, 18, and 13, which is promptly becoming a common clinical practice. Concerned about the clinical application of non‐invasive detection of the fetal autosomal duplications or deletion.Case Presentation: A 34‐year‐old, healthy pregnant woman was referred to the First Affiliated Hospital of the Air Force Medical University. The ultrasound examination indicates that low‐lying placenta, the fetus has a left ventricular bright spot and small amount of pericardial effusion. NIPT was chosen to further screen for fetal chromosomal abnormalities. NIPT results indicated an approximately 18 Mb deletion, which was verified by prenatal diagnosis. The chromosome microarray analysis (CMA) result showed about 19.2 Mb deletions in 21q11.2‐q22.11. The karyotype analysis result showed 46,XN,del(21)(q11.2q22.1). Prenatal diagnosis was consistent with NIPT results, and the paternal karyotype revealed no obvious abnormalities.Conclusion: In this study, we successfully detected and diagnosed deletions of large fragments in chromosome 21 in a fetus using NIPT. This indicates that NIPT can provide effective genetic information for detecting fetal subchromosomal deletions/duplications.